Concepedia

Jan‐Henrik Mikesch

JM

Statistics

Publications

42

Citations

1.4K

H-Index

20

Active since

2013

Affiliations

University Hospital Münster(Current)

Heidelberg University

University of Münster

University Hospital Heidelberg

Goethe University Frankfurt

Jan‐Henrik Mikesch is an author at University Hospital Münster specializing in medicine, oncology, and acute myeloid leukemia therapy.

ORCID

Publications per year

2013–2025

42

Publications

42

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of <i>FLT3</i>

Mark J. Levis, Mehdi Hamadani, Brent R. Logan et al. · Journal of Clinical Oncology · 2024 · 185 citations · Full text

, , +11

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

Christoph Röllig, Michael Krämer, Christoph Schliemann et al. · Blood · 2020 · 135 citations · Full text

, , +7

EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells

Sareetha Kailayangiri, Bianca Altvater, Stefanie Lesch et al. · Molecular Therapy · 2019 · 123 citations · Full text

, , +17

A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy

Maxi Wass, Stefanie Göllner, Birgit Besenbeck et al. · Leukemia · 2020 · 97 citations · Full text

, , +3

The Histone Demethylase PHF8 Governs Retinoic Acid Response in Acute Promyelocytic Leukemia

Marı́a Francisca Arteaga, Jan‐Henrik Mikesch, Jihui Qiu et al. · Cancer Cell · 2013 · 86 citations · Full text

, , +12

1–5 of 42